Efficacy and tolerability of vemurafenib in patients with BRAFV600E positive papillary thyroid cancer: M.D. Anderson Cancer center off label experience
Dive into the research topics of 'Efficacy and tolerability of vemurafenib in patients with BRAFV600E positive papillary thyroid cancer: M.D. Anderson Cancer center off label experience'. Together they form a unique fingerprint.